To compare the clinical efficacy of superpath approach and modified Hardinge approach in total hip arthroplasty in patients with femoral neck fracture: a randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041583

Enrollment

Unknown

Registered

2020-12-31

Start date

2018-01-23

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral neck fracture

Interventions

Supepath group:SuperPath approach

Conventional group:Modified Hardinge approach

Eligibility

Sex/Gender

All

Age

49 Years to 93 Years

Inclusion criteria

Inclusion criteria: 1. Patients with fresh femoral neck fracture (Garden III and IV type); 2. For femoral neck fracture, the operation method is total hip arthroplasty through superpath minimally invasive approach or modified Hardinge approach; 3. Patients who have the ability to complete the planned 12-month follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with pathological fracture, necrosis of femoral head and hip arthritis; 2. Patients with hip joint disease before fracture have severe anatomical deformity and dysfunction of hip joint; 3. Patients with body mass index (BMI) > 30 kg / m2.

Design outcomes

Primary

Measure	Time frame
Harris Hip Score;visual analogue scale;Operation time;	—

Secondary

Measure	Time frame
Intraoperative blood loss;Incision length;Hospitalization time;Drainage volume;Transfusion rate;Hemoglobin;Hematocrit;C-reactive protein;erythrocyte sedimentation rate;creatine kinase;	—

Countries

China

Contacts

Public ContactJiwei Ping

The People's Hospital of Lishui

2276085@vip.sina.com+86 13905888686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026